JP2024500605A5 - - Google Patents
Info
- Publication number
- JP2024500605A5 JP2024500605A5 JP2023526518A JP2023526518A JP2024500605A5 JP 2024500605 A5 JP2024500605 A5 JP 2024500605A5 JP 2023526518 A JP2023526518 A JP 2023526518A JP 2023526518 A JP2023526518 A JP 2023526518A JP 2024500605 A5 JP2024500605 A5 JP 2024500605A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- receptor
- activity
- glucagon
- gip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2020-0183576 | 2020-12-24 | ||
| KR20200183576 | 2020-12-24 | ||
| PCT/KR2021/019791 WO2022139538A1 (ko) | 2020-12-24 | 2021-12-24 | 신규한 글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중활성체 및 이의 용도 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024500605A JP2024500605A (ja) | 2024-01-10 |
| JP2024500605A5 true JP2024500605A5 (https=) | 2025-01-08 |
Family
ID=82159979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526518A Pending JP2024500605A (ja) | 2020-12-24 | 2021-12-24 | 新規なグルカゴン、ｇｌｐ－１及びｇｉｐ受容体の全てに対して活性を有する三重活性体及びその用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230382974A1 (https=) |
| EP (1) | EP4269425A4 (https=) |
| JP (1) | JP2024500605A (https=) |
| KR (1) | KR20220092442A (https=) |
| CN (1) | CN116635050A (https=) |
| WO (1) | WO2022139538A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12281149B2 (en) | 2021-05-13 | 2025-04-22 | Carmot Therapeutics, Inc. | Modulators of G-protein coupled receptors |
| KR20250177377A (ko) * | 2024-06-13 | 2025-12-23 | 한미약품 주식회사 | Glp-1, gip, 및 글루카곤 수용체 모두에 활성을 갖는 삼중 활성체 및 이를 포함하는 당뇨 예방 또는 치료용 약학적 조성물 |
| KR20250177375A (ko) * | 2024-06-13 | 2025-12-23 | 한미약품 주식회사 | Glp-1, gip, 및 글루카곤 수용체 모두에 활성을 갖는 삼중 활성체 및 이를 포함하는 지질 대사 질환 예방 또는 치료용 약학적 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| JP4046354B2 (ja) | 1996-03-18 | 2008-02-13 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 増大した半減期を有する免疫グロブリン様ドメイン |
| AR092873A1 (es) * | 2012-09-26 | 2015-05-06 | Cadila Healthcare Ltd | Peptidos como agonistas triples de los receptores de gip, glp-1 y glugagon |
| CN105829339B (zh) * | 2013-11-06 | 2021-03-12 | 西兰制药公司 | 胰高血糖素-glp-1-gip三重激动剂化合物 |
| SG11201805586SA (en) | 2015-12-31 | 2018-07-30 | Hanmi Pharmaceutical Co Ltd | Triple glucagon/glp-1/gip receptor agonist |
| CN113453703A (zh) * | 2018-12-21 | 2021-09-28 | 韩美药品株式会社 | 包括胰岛素和对胰高血糖素和glp-1和gip受体均具有活性的三重激动剂的药物组合物 |
| WO2020214013A1 (ko) * | 2019-04-19 | 2020-10-22 | 한미약품 주식회사 | 글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체 또는 이의 결합체의 고지혈증에 대한 치료적 용도 |
-
2021
- 2021-12-24 KR KR1020210187212A patent/KR20220092442A/ko active Pending
- 2021-12-24 EP EP21911603.5A patent/EP4269425A4/en active Pending
- 2021-12-24 JP JP2023526518A patent/JP2024500605A/ja active Pending
- 2021-12-24 CN CN202180080610.5A patent/CN116635050A/zh active Pending
- 2021-12-24 US US18/250,150 patent/US20230382974A1/en active Pending
- 2021-12-24 WO PCT/KR2021/019791 patent/WO2022139538A1/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024500605A5 (https=) | ||
| TWI413528B (zh) | 使用免疫球蛋白片段的促胰島素複合物 | |
| CN108136276B (zh) | 通过使用免疫球蛋白片段的特异性位点进行连接的蛋白质复合物 | |
| AU2003272970B2 (en) | GLP-1 derivatives and transmicosal absorption preparations thereof | |
| JP2010515686A5 (https=) | ||
| US20140105896A1 (en) | Fibronectin based scaffold domain proteins that bind to myostatin | |
| DK2633865T3 (en) | USE OF INTERLEUKIN-22 IN THE TREATMENT OF VIRAL HEPATITIS | |
| KR20120010146A (ko) | 신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물 | |
| JP2019524675A5 (https=) | ||
| JP2020513019A (ja) | オリゴマー伸長インスリン−Ｆｃコンジュゲート | |
| FI3368555T3 (fi) | Kaksitoimisia proteiineja ja niitä sisältävä farmaseuttinen koostumus | |
| RU2007119990A (ru) | Слитые конструкции лекарственного средства и конъюгаты | |
| JP2010500996A5 (https=) | ||
| JP2006514607A5 (https=) | ||
| JP2020513019A5 (https=) | ||
| JP2022551282A5 (https=) | ||
| JP2016532681A5 (https=) | ||
| JP2025504625A5 (https=) | ||
| JP2020512287A5 (https=) | ||
| JP5751641B2 (ja) | メラノコルチン受容体結合コンジュゲート | |
| RU2007119989A (ru) | Композиции, слитые конструкции и конъюгаты plad домена | |
| JP2021531834A5 (https=) | ||
| TW201808344A (zh) | 聚乙二醇衍生物及其用途 | |
| JP2024504923A5 (https=) | ||
| JP2024527613A5 (https=) |